$3,682.56 travel Payment -- Pfizer Inc to Dr. Joseph Carter

Pfizer Inc. covers $3,682.56 in travel and lodging for Neurology physician Joseph Carter related to Spinraza.

This page provides a detailed analysis of a $3,682.56 travel payment from Pfizer Inc to Dr. Joseph Carter. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$3,682.56
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyPfizer Inc
PhysicianDr. Joseph Carter
NPI Number1778587660
Physician SpecialtyNeurology
LocationBuffalo, NY
Date of Payment2024-05-01
Related Drug/DeviceSpinraza
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Pfizer Inc made a $3.7K travel payment to Joseph Carter, a Neurology specialist in Buffalo, NY. The payment was associated with Spinraza. The payment of $3,682.56 to Dr. Joseph Carter from Pfizer Inc. for travel and lodging related to Spinraza is a significant amount for a single trip. This payment covers travel and lodging, suggesting an educational event or a site visit related to Spinraza. The payment was made on May 1, 2024, indicating a recent engagement between the physician and the pharmaceutical company.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging expenses. If you are a patient, discuss any concerns about your treatment or associated costs with your doctor. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For a neurologist, travel and lodging payments can be common for attending medical conferences or educational events related to specific treatments like Spinraza, but the amount should be reviewed for appropriateness.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging by pharmaceutical companies to physicians are subject to disclosure under the Sunshine Act and must comply with regulations designed to prevent conflicts of interest.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.7K payment for?

This was a travel payment of $3.7K from Pfizer Inc to Joseph Carter, categorized as "Travel and Lodging". It was associated with Spinraza. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Joseph Carter accept pharmaceutical money?

Yes, Joseph Carter received this $3.7K payment from Pfizer Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Joseph Carter's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.7K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Neurology?

To compare this payment against Neurology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Neurology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Joseph Carter's relationship with Pfizer Inc?

The payment amount is substantial for travel and lodging, warranting further investigation into the nature of the expenses. This $3.7K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Neurology?

The specific drug associated with the payment is Spinraza, a treatment for spinal muscular atrophy.

What should patients do after learning about this payment?

This payment covers travel and lodging expenses. If you are a patient, discuss any concerns about your treatment or associated costs with your doctor.

What else should I know about this travel payment?

The payment was made to a neurologist, a relevant specialty for a drug like Spinraza.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.